BioLife Solutions (NASDAQ:BLFS) has agreed to sell SAVSU Cleo Technologies, LLC. (formerly SAVSU Technologies, Inc.), its wholly owned cold chain logistics subsidiary, to Peli BioThermal, a global ...

Fast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s differentiated, high-margin recurring revenue business BioLife stockholders to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems ...

The MarketWatch News Department was not involved in the creation of this content. BOTHELL, Wash., Feb. 17, 2026 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier ...

BioLife Solutions is headquartered in Bothell, WA. BioLife Solutions manufactures and markets bioproduction tools and services for the cell and gene therapy (CGT) industry. The stock currently trades ...

Life shrinks or expands in proportion to one's courage.”― Anais Nin. Shares of cell and gene therapy logistics concern BioLife Solutions, Inc. (BLFS) are trading near 52-week lows as the company’s ...

BioLife Solutions, a Bothell, Wash.-based company developing tools for cell and gene therapy, is being acquired for $1.5 billion by the life sciences corporation Repligen. BioLife is a publicly traded ...

BOTHELL, Wash., March 22, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction ...

Chief Executive Officer Mike Rice said, "We are currently in a hiring and expansion phase, thanks to the growth of our customer base and increased demand for our products. Our new corporate facilities ...